Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-25-000641
Filing Date
2025-01-06
Accepted
2025-01-06 17:24:03
Documents
25
Period of Report
2025-01-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A twst-20250106.htm   iXBRL DEF 14A 1875412
6 twst-20250106_g1.jpg GRAPHIC 10009
7 twst-20250106_g2.jpg GRAPHIC 883
8 twst-20250106_g3.jpg GRAPHIC 22350
9 twst-20250106_g4.jpg GRAPHIC 26458
10 twst-20250106_g5.jpg GRAPHIC 68478
11 twst-20250106_g6.jpg GRAPHIC 260900
12 twst-20250106_g7.jpg GRAPHIC 181741
13 twst-20250106_g8.jpg GRAPHIC 176010
14 twst-20250106_g9.jpg GRAPHIC 538281
  Complete submission text file 0001628280-25-000641.txt   5668191

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT twst-20250106.xsd EX-101.SCH 2343
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT twst-20250106_def.xml EX-101.DEF 2337
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT twst-20250106_lab.xml EX-101.LAB 2611
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT twst-20250106_pre.xml EX-101.PRE 1418
27 EXTRACTED XBRL INSTANCE DOCUMENT twst-20250106_htm.xml XML 155839
Mailing Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 800-719-0671
Twist Bioscience Corp (Filer) CIK: 0001581280 (see all company filings)

EIN.: 462058888 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-38720 | Film No.: 25512409
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)